Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-157,445
Closed -$15.1M 1592
2025
Q2
$15.1M Sell
157,445
-35,386
-18% -$3.35M 0.01% 762
2025
Q1
$17.9M Buy
192,831
+192,808
+838,296% +$17.8M 0.01% 728
2024
Q4
$2.12K Sell
23
-294,588
-100% -$27.1M ﹤0.01% 1988
2024
Q3
$28.4M Buy
294,611
+18,000
+7% +$1.76M 0.01% 651
2024
Q2
$26.9M Buy
276,611
+48,196
+21% +$4.47M 0.01% 650
2024
Q1
$20.7M Sell
228,415
-6,025
-3% -$565K 0.01% 695
2023
Q4
$21.9M Sell
234,440
-53,353
-19% -$4.98M 0.01% 701
2023
Q3
$26.7M Buy
287,793
+162,549
+130% +$15M 0.01% 646
2023
Q2
$11.4M Buy
125,244
+3,158
+3% +$259K 0.01% 817
2023
Q1
$9.4M Sell
122,086
-19,452
-14% -$1.68M 0.01% 851
2022
Q4
$11.5M Buy
141,538
+11,703
+9% +$1.06M 0.01% 825
2022
Q3
$13M Sell
129,835
-95,944
-42% -$11.4M 0.01% 784
2022
Q2
$27.5M Buy
225,779
+4,835
+2% +$618K 0.02% 558
2022
Q1
$36.9M Buy
220,944
+54,443
+33% +$8.13M 0.03% 525
2021
Q4
$24.4M Sell
166,501
-9,706
-6% -$1.56M 0.02% 635
2021
Q3
$26.3M Sell
176,207
-19,786
-10% -$4.11M 0.02% 614
2021
Q2
$48M Buy
+195,993
New +$51.4M 0.03% 454

Other funds holding AMED

Amundi's AMED Position: Q3 2025 in Review

Amundi sold out of Amedisys (AMED) in Q3 2025, closing a stake of 157,445 shares — an estimated $15.1M sold.

Amundi first reported a position in AMED in Q2 2021 and held it in 17 quarters. The position peaked at $48M in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Amundi reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Amundi sold 157,445 Amedisys shares in Q3 2025, an estimated $15.1M.
  • Amundi first reported a position in Amedisys in Q2 2021 and held it in 17 quarters.
  • Amundi's Amedisys position peaked at $48M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Amundi's 13F filing for Q3 2025, filed 14 Nov 2025.